An observational study of the discrediting of COX-2 NSAIDs in Australia
Vioxx or class effect
Bibliographic Data
| ID | 15375255 |
|---|---|
| Authors | Lynne Parkinson (0000-0001-9433-9555, University of Newcastle Australia, corresponding author), Xenia Dolja‐Gore (0000-0002-7085-8024, University of Newcastle Australia), Richard Gibson (0000-0001-5412-1965, University of Newcastle Australia), Evan Doran (0000-0002-3025-0524, University of Newcastle Australia), Lisa Notley (University of Newcastle Australia), Jennifer Stewart Williams (0000-0001-6533-0762, University of Newcastle Australia), Jenny Stewart Williams, Paul Kowal (0000-0002-6314-8753, University of Newcastle Australia), Julie E Byles, Julie Byles (0000-0002-3984-6877, University of Newcastle Australia) |
| Year | 2011 |
| Volume | 11 |
| Issue | 1 |
| Pages | 892-892 |
| Publication date | 2011-11-24 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | BMC Public Health (JOURNAL) |
| Journal identifiers | ISSN: 1471-2458 • E-ISSN: 1471-2458 |
| Publisher | BioMed Central (PUBLISHER • GB) |
| DOI | 10.1186/1471-2458-11-892 |
| PMID | 22114865 |
| PMCID | PMC3280381 |
| OpenAlex | W2158917195 |
| Language | EN |
| References cited | 33 |
The typical switching behaviour of this group of women suggests that the issues leading to the discrediting of rofecoxib were not seen as a COX-2 class effect by prescribers to this high use group of consumers
Biostatistics · Observational study · Public health · Demography · Healthcare Quality and Management · Inflammatory mediators and NSAID effects · Medicine · Nursing · Pharmaceutical industry and healthcare · Epidemiology · Internal Medicine
| Highly cited | No |
|---|